• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电负性 LDL:动脉粥样硬化形成中的活跃因子还是动脉粥样硬化的副产物?

Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?

机构信息

Cardiovascular Biochemistry Group, Research Institute of the Hospital de Sant Pau (IIB Sant Pau), Barcelona, Spain.

Biochemistry and Molecular Biology Department, Universitat Autònoma de Barcelona, Cerdanyola, Spain.

出版信息

Curr Med Chem. 2019;26(9):1665-1679. doi: 10.2174/0929867325666180330093953.

DOI:10.2174/0929867325666180330093953
PMID:29600751
Abstract

Low-density lipoproteins (LDLs) are the major plasma carriers of cholesterol. However, LDL particles must undergo various molecular modifications to promote the development of atherosclerotic lesions. Modified LDL can be generated by different mechanisms, but as a common trait, show an increased electronegative charge of the LDL particle. A subfraction of LDL with increased electronegative charge (LDL(-)), which can be isolated from blood, exhibits several pro-atherogenic characteristics. LDL(-) is heterogeneous, due to its multiple origins but is strongly related to the development of atherosclerosis. Nevertheless, the implication of LDL(-) in a broad array of pathologic conditions is complex and in some cases anti-atherogenic LDL(-) properties have been reported. In fact, several molecular modifications generating LDL(-) have been widely studied, but it remains unknown as to whether these different mechanisms are specific or common to different pathological disorders. In this review, we attempt to address these issues examining the most recent findings on the biology of LDL(-) and discussing the relationship between this LDL subfraction and the development of different diseases with increased cardiovascular risk. Finally, the review highlights the importance of minor apolipoproteins associated with LDL(-) which would play a crucial role in the different properties displayed by these modified LDL particles.

摘要

低密度脂蛋白(LDLs)是胆固醇的主要血浆载体。然而,LDL 颗粒必须经历各种分子修饰才能促进动脉粥样硬化病变的发展。修饰的 LDL 可以通过不同的机制产生,但作为一个共同的特征,显示 LDL 颗粒的负电性增加。LDL(LDL(-))的一个亚组分,其带电量增加,可以从血液中分离出来,表现出几种促动脉粥样硬化的特征。LDL(-)是异质的,由于其多种来源,但与动脉粥样硬化的发展密切相关。然而,LDL(-)在广泛的病理条件下的影响是复杂的,在某些情况下,已经报道了抗动脉粥样硬化的 LDL(-)特性。事实上,已经广泛研究了产生 LDL(-)的几种分子修饰,但尚不清楚这些不同的机制是否是特定的,还是与不同的病理紊乱共同的。在这篇综述中,我们试图通过检查 LDL(-)生物学的最新发现来解决这些问题,并讨论这种 LDL 亚组分与增加心血管风险的不同疾病的发展之间的关系。最后,综述强调了与 LDL(-)相关的小载脂蛋白的重要性,它们在这些修饰的 LDL 颗粒显示的不同特性中发挥着关键作用。

相似文献

1
Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?电负性 LDL:动脉粥样硬化形成中的活跃因子还是动脉粥样硬化的副产物?
Curr Med Chem. 2019;26(9):1665-1679. doi: 10.2174/0929867325666180330093953.
2
[Atherogenic modification of low-density lipoproteins].[低密度脂蛋白的致动脉粥样硬化修饰]
Biomed Khim. 2016 May;62(4):391-402. doi: 10.18097/PBMC20166204391.
3
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease.载脂蛋白 L5 和 Lp(a)在动脉粥样硬化性心血管疾病中的对比分析。
Curr Atheroscler Rep. 2024 Jul;26(7):317-329. doi: 10.1007/s11883-024-01209-3. Epub 2024 May 16.
4
Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein.天然存在的修饰去唾液酸、带负电荷的主动脉低密度脂蛋白之间的相似性。
Free Radic Res. 1996 Oct;25(4):313-9. doi: 10.3109/10715769609149054.
5
Aggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion.人血浆中聚集的电负性低密脂蛋白显示出很高的磷脂酶解和颗粒融合倾向。
J Biol Chem. 2010 Oct 15;285(42):32425-35. doi: 10.1074/jbc.M110.139691. Epub 2010 Jul 29.
6
Misfolding of apoprotein B-100, LDL aggregation and 17-β -estradiol in atherogenesis.载脂蛋白 B-100 错误折叠、LDL 聚集和 17-β -雌二醇在动脉粥样硬化形成中的作用。
Curr Med Chem. 2014;21(20):2276-83. doi: 10.2174/0929867321666140120114944.
7
Thermal stability of human plasma electronegative low-density lipoprotein: A paradoxical behavior of low-density lipoprotein aggregation.人血浆中带负电的低密度脂蛋白的热稳定性:低密度脂蛋白聚集的一种矛盾行为。
Biochim Biophys Acta. 2016 Sep;1861(9 Pt A):1015-1024. doi: 10.1016/j.bbalip.2016.05.008. Epub 2016 May 24.
8
Aggregation and fusion of low-density lipoproteins in vivo and in vitro.低密度脂蛋白在体内和体外的聚集与融合。
Biomol Concepts. 2013 Oct;4(5):501-18. doi: 10.1515/bmc-2013-0016.
9
Electronegative low-density lipoprotein. A link between apolipoprotein B misfolding, lipoprotein aggregation and proteoglycan binding.电负性低密度脂蛋白。载脂蛋白 B 错误折叠、脂蛋白聚集和蛋白聚糖结合之间的联系。
Curr Opin Lipidol. 2012 Oct;23(5):479-86. doi: 10.1097/MOL.0b013e328357c933.
10
LDL electronegativity index: a potential novel index for predicting cardiovascular disease.低密度脂蛋白负电指数:一种预测心血管疾病的潜在新指标。
Vasc Health Risk Manag. 2015 Aug 28;11:525-32. doi: 10.2147/VHRM.S74697. eCollection 2015.

引用本文的文献

1
Alterations in LDL and HDL after an ischemic stroke associated with carotid atherosclerosis are reversed after 1 year.与颈动脉粥样硬化相关的缺血性中风后,低密度脂蛋白和高密度脂蛋白的改变在1年后会逆转。
J Lipid Res. 2025 Feb;66(2):100739. doi: 10.1016/j.jlr.2024.100739. Epub 2024 Dec 31.
2
We Must Abandon the Myth: Oxidized Low-density Lipoprotein is not a Lipoprotein that Plays a Key Role in Atherogenesis.我们必须摒弃这一错误观念:氧化型低密度脂蛋白并非在动脉粥样硬化形成中起关键作用的脂蛋白。
Curr Med Chem. 2025;32(15):2899-2914. doi: 10.2174/0109298673301236240311113807.
3
Can Electronegative LDL Act as a Multienzymatic Complex?
负电性 LDL 可否充当多酶复合物?
Int J Mol Sci. 2023 Apr 11;24(8):7074. doi: 10.3390/ijms24087074.
4
Presence of Ceramidase Activity in Electronegative LDL.电负性 LDL 中 Ceramidase 活性的存在。
Int J Mol Sci. 2022 Dec 22;24(1):165. doi: 10.3390/ijms24010165.
5
Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL.基于新型药物和营养保健品的心血管疾病预防方法:靶向致动脉粥样硬化的小而密低密度脂蛋白
Pharmaceutics. 2022 Apr 9;14(4):825. doi: 10.3390/pharmaceutics14040825.
6
The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism.高密度脂蛋白亚群对脂蛋白脂肪酶(LPL)介导的极低密度脂蛋白分解代谢的差异影响。
Biomedicines. 2021 Dec 5;9(12):1839. doi: 10.3390/biomedicines9121839.
7
Circulating Biomarkers Reflecting Destabilization Mechanisms of Coronary Artery Plaques: Are We Looking for the Impossible?反映冠状动脉斑块不稳定机制的循环生物标志物:我们在寻找不可能的事情吗?
Biomolecules. 2021 Jun 14;11(6):881. doi: 10.3390/biom11060881.
8
Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis.电负性低密度脂蛋白胆固醇在动脉粥样硬化血栓形成中的临床意义
Biomedicines. 2020 Jul 30;8(8):254. doi: 10.3390/biomedicines8080254.
9
Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113-122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice.皮下给予载脂蛋白 J 衍生模拟肽 d-[113-122]apoJ 可改善 LDL 和 HDL 功能并预防 LDLR-KO 小鼠的动脉粥样硬化。
Biomolecules. 2020 May 29;10(6):829. doi: 10.3390/biom10060829.
10
Binding to heparin triggers deleterious structural and biochemical changes in human low-density lipoprotein, which are amplified in hyperglycemia.与肝素结合会引发人低密度脂蛋白产生有害的结构和生化变化,这种变化在高血糖症中会被放大。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Aug;1865(8):158712. doi: 10.1016/j.bbalip.2020.158712. Epub 2020 Apr 11.